Extracellular vesicles in gastrointestinal cancer in conjunction with microbiota: On the border of Kingdoms

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1868, Issue 2, 2017, Pages 372-393

  Barteneva, Natasha S ^a   Baiken, Yeldar ^b   Fasler Kan, Elizaveta ^c,d   Alibek, Kenneth ^b,i   Wang, Sheng ^e,j   Maltsev, Natalia ^e   Ponomarev, Eugene D ^f   Sautbayeva, Zarina ^b   Kauanova, Sholpan ^b   Moore, Anna ^g   Beglinger, Christoph ^h   Vorobjev, Ivan A ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NAZARBAYEV UNIVERSITY   (Kazakhstan)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY OF CHICAGO   (United States)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁱ Locus Solutions Inc   (United States)

^j KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Saudi Arabia)

more..

Author keywords

Bacteroides fragilis; Exosomes; Extracellular vesicles; Gastrointestinal cancer; Inter species communication; Pseudokinase

Indexed keywords

AMINO ACID; CELL PROTEIN; MICROBIAL ENZYME; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN PSEUDOKINASE; PROTEOME; RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; BACTEROIDES FRAGILIS; CANCER RESEARCH; CELL COMMUNICATION; CELL STRUCTURE; CELL SURVIVAL; CHRONIC INFLAMMATION; COEVOLUTION; DIGESTIVE SYSTEM CANCER; EARLY DIAGNOSIS; EDIBLE PLANT; EUKARYOTIC CELL; EXOSOME; EXTRACELLULAR SPACE; FUNGUS; GENETIC CONSERVATION; HUMAN; INFLAMMATORY DISEASE; INTESTINE FLORA; INTRACELLULAR SPACE; MOLECULAR MIMICRY; NONHUMAN; PARASITE; PRIORITY JOURNAL; REVIEW; RNA DEGRADATION; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; TUMOR CELL; ANIMAL; GASTROINTESTINAL TUMOR; PHYSIOLOGY;

ANIMALS; CELL COMMUNICATION; EXTRACELLULAR VESICLES; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL NEOPLASMS; HUMANS; MOLECULAR MIMICRY; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA;

EID: 85026814252     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2017.06.005     Document Type: Review

References (303)

1. Balkwill, F., Mantovani, A., Inflammation and cancer: back to Virchow?. Lancet 357 (2001), 539–545.
2. Lowenfels, A.B., Maisonneuve, P., Cavallini, G., Ammann, R.W., Lankisch, P.G., Andersen, J.R., Dimagno, E.P., Andrén-Sandberg, A., Domellöf, L., Pancreatitis and the risk of pancreatic cancer, International Pancreatitis Study Group. N. Engl. J. Med. 328 (2003), 1433–1437.
3. Itzkowiz, S.H., Yio, X., Inflammation and cancer. IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 287 (2004), G7–G17.
4. Wroblewski, L.E., Peek, R.M., Wilson, K.T., Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin. Microbiol. Rev. 23 (2010), 713–779.
5. Tomita, Y., Azuma, K., Nonaka, Y., Kamada, Y., Tomoeda, M., Kishida, M., Tanemura, M., Miyoshi, E., Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma. Pancreas 43 (2014), 1032–1041.
6. Axelrad, J.E., Lichtiger, S., Yajnik, V., Inflammatory bowel disease and cancer. The role of inflammation, immunosuppression, and cancer treatment. World J. Gastroenterol. 22 (2016), 4794–4801, 10.3748/wjg.v22.i20.4794.
7. Virchow, R., Cellular Pathology as Based Upon Physiological and Pathological Histology. 1863, Lippincott, Philadelphia.
8. Coussens, L.M., Werb, Z., Inflammation and cancer. Nature 420 (2002), 860–867.
9. Parkin, D.M., Pisani, P., Munoz, N., Ferlay, J., Newton, R., Beral, V., Weiss, R.A., (eds.) Infections and Human Cancer, 1999, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
10. Ernst, P.B., Gold, B.D., The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu. Rev. Microbiol. 54 (2000), 615–640.
11. Muller, G., Novel tools for the study of cell type-specific exosomes and microvesicles. J. Bioanal. Biomed. 4 (2012), 46–60.
12. McDaniel, K., Correa, R., Zhou, T., Johnson, C., Francis, H., Glaser, S., Venter, J., Alpini, G., Meng, F., Functional role of microvesicles in gastrointestinal malignancies. Ann. Transl. Med., 1, 2013, 4.
13. Barteneva, N.S., Fasler-Kan, E., Bernimoulin, M., Stern, J.N., Ponomarev, E.D., Duckett, L., Vorobjev, I.A., Circulating microparticles: square the circle. BMC Cell Biol., 14, 2013, 23, 10.1186/1471-2121-14-23.
14. Lemoinne, S., Thabut, D., Housset, C., Moreau, R., Valla, D., Boulanger, C.M., Rautou, P.E., The emerging roles of microvesicles in liver diseases. Nat. Rev. Gastroenterol. Hepatol. 11 (2014), 350–361, 10.1038/nrgastro.2014.7.
15. Telford, J.J., Enns, R.A., Endoscopic missed rates of upper gastrointestinal cancers: parallels with colonoscopy. Am. J. Gastroenterol. 105 (2010), 1298–1300, 10.1038/ajg.2009.739.
16. Bressler, B., Paszat, L.F., Chen, Z., Rothwell, D.M., Vinden, C., Rabeneck, L., Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology 132 (2007), 96–102.
17. Fisher, D.A., Maple, J.T., Ben-Menachem, T., Cash, B.D., Decker, G.A., Early, D.S., Evans, J.A., Fanelli, R.D., Fukami, N., Hwang, J.H., Jain, R., Jue, T.L., Khan, K.M., Malpas, P.M., Sharaf, R.N., Shergill, A.K., Dominitz, J.A., Complications of colonoscopy. Gastrointest. Endosc. 74 (2011), 745–752, 10.1016/j.gie.2011.07.025.
18. El Andaloussi, S., Maegger, L., Breakefield, X.O., Wood, M.J.A., M.J.A., Extracellular vesicles: biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov. 12 (2013), 347–357, 10.1038/nrd3978.
19. Raposo, G., Stoorvogel, W., Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200 (2013), 373–383, 10.1083/jcb.201211138.
20. Lee, J.K., Park, S.R., Jung, B.K., Jeon, Y.K., Lee, Y.S., Kim, M.K., Kim, Y.G., Jang, J.Y., Kim, C.W., Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS One, 8, 2013, e84256, 10.1371/journal.pone.0084256.
21. Deatherage, B.L., Cookson, B.T., Membrane vesicles release in bacteria, eukaryotes, and archea: a conserved yet underappreciated aspect of microbial life. Infect. Immun. 80 (2012), 1949–1957.
22. Berleman, J., Auer, M., The role of bacterial outer membrane vesicles for intra- and interspecies delivery. Environ. Microbiol. 15 (2013), 347–354, 10.1111/1462-2920.12048 (347-54).
23. Schwechheimer, C., Kuehn, M.J., Outer-membrane vesicles from gram-negative bacteria: biogenesis and functions. Nat. Rev. Microbiol. 13 (2015), 605–619, 10.1038/nrmicro3525.
24. Kaparakis-Liaskos, M., Ferrero, R.L., Immune modulation by bacterial outer membrane vesicles. Nat. Rev. Immunol. 15 (2015), 375–387, 10.1038/nri3837.
25. Salzer, U., Hinterdorfer, P., Hunger, U., Borken, C., Prohaska, R., Ca(++)-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. Blood 99 (2002), 2569–2577.
26. Davizon, P., Munday, A.D., Lopez, J.A., Tissue factor, lipid rafts, and microparticles. Semin. Thromb. Hemost. 36 (2010), 857–864.
27. Nickel, W., Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells. Traffic 6 (2005), 607–614.
28. D'Souza-Schorey, C., Clancy, J.W., Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev. 26 (2012), 1287–1299.
29. Coccucci, E., Meldolesi, J., Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol. 25:6 (2015), 364–372.
30. Escola, J.M., Kleijmeer, M.J., Stoorvogel, W., Griffith, J.M., Yoshie, O., Geuze, H.J., Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J. Biol. Chem. 273 (1998), 20121–20127.
31. Andreu, Z., Yanez-Mo, M., Tetraspanins in extracellular vesicle formation and function. Front. Immunol., 5, 2014, 442, 10.3389/fimmu.2014.00442.
32. Hurwitz, S.N., Conlon, M.M., Rider, M.A., Brownstein, N.C., Meckes, D.G. Jr., Nanoparticle analysis sheds budding insights into genetic drivers of extracellular vesicles biogenesis. J. Extracell. Vesicles, 5, 2016, 31295, 10.3402/jev.v5.31295.
33. Sadallah, S., Eken, C., Schifferli, J.A., Erythrocyte-derived ectosomes have immunosuppressive properties. J. Leukoc. Biol. 84 (2008), 1316–1325, 10.1189/jlb.0108013.
34. Laulagnier, K., Motta, C., Hamdi, S., Roy, S., Fauvelle, F., Pageaux, J.F., Kobayashi, T., Salles, J.P., Perret, B., Bonnerot, C., Record, M., Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. Biochem. J. 380 (2004), 161–171.
35. Record, M., Carayon, K., Poirot, M., Silvente-Poirot, S., Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim. Biophys. Acta 1841 (2014), 108–120, 10.1016/j.bbalip.2013.10.004.
36. Luketic, L., Delanghe, J., Sobol, P.T., Yang, P., Frotten, E., Mossman, K.L., Gauldie, J., Bramson, J., Wan, Y., Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL. J. Immunol. 179 (2007), 5024–5032.
37. Muralidharan-Chari, V., Clancy, J.W., Sedgwick, A., D'Souza-Schorey, C., Microvesicles: mediators of extracellular communication during cancer progression. J. Cell Sci. 123 (2010), 1603–1611, 10.1242/jcs.064386.
38. Thery, C., Zitvogel, L., Amigorena, S., Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2 (2002), 569–579.
39. Cocucci, E., Racchetti, G., Meldolesi, J., Shedding microvesicles: artefacts no more. Trends Cell Biol. 19 (2009), 43–51.
40. Tauro, B.J., Greening, D.W., Mathias, R.A., Ji, H., Mathivanan, S., Scott, A.M., Simpson, R.J., Comparison of ultracentrifugation, density gradient separation and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods 56 (2012), 293–304, 10.1016/j.ymeth.2012.01.002.
41. Witwer, K.W., Buzas, E.I., Bemis, L.T., Bora, A., Laesser, C., Lötvall, J., Nolte-’t Hoen, E.N., Piper, M.G., Sivaraman, S., Skog, J., Théry, C., Wauben, M.H., Hochberg, F., F., Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J. Extracel. Vesicles, 2(2013), 2013, 10.3402/jev.v2i0.20360.
42. van der Pol, E., Coumans, F.A., Grootemaat, A.E., Gardiner, C., Sargent, L.L., Harrison, P., Sturk, A., van Leewen, T.G., Niewland, R., Particle size distribution of exosomes and microvesicles determined by transmisssion electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing. J. Thromb. Haemost. 12 (2014), 1182–1192.
43. Gaudin, R., Barteneva, N.S., Sorting of small infectious virus particles by flow virometry reveals distinctive infectivity profiles. Nat. Commun., 6, 2015, 6022, 10.1038/ncomms7022.
44. Laesser, C., Alikhani, V.S., Ekstroem, K., Eldh, M., Paredes, P.T., Bossios, A., Sjöstrand, M., Gabrielsson, S., Lötvall, J., Valadi, H., Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J. Transl. Med., 9, 2011, 9, 10.1186/1479-5876-9-9.
45. Waldenstroem, A., Gennebaeck, N., Hellman, U., Ronquist, G., Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS One, 7, 2012, e34653, 10.1371/journal.pone.0034653.
46. Taylor, D.D., Gercel-Taylor, C., The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluids. Front. Genet., 4, 2013, 142i, 10.3389/fgene.2013.00142.
47. Jin, Y., Chen, K., Wang, Z., Wang, Y., Liu, J., Shao, Y., Gao, L., Yin, H., Cui, C., Tan, Z., Liu, L., Zhao, C., Zhang, G., Jia, R., Du, L., Chen, Y., Liu, R., Xu, J., Hu, X., Wang, Y., DNA in serum extracellular vesicles is stable under different storage conditions. BMC Cancer, 16, 2016, 753.
48. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J.J., Lotvall, J.O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9 (2007), 654–659.
49. Lovren, F., Verma, S., Evolving role of microparticles in the pathophysiology of endothelial dysfunction. Clin. Chem. 59 (2013), 1166–1174, 10.1373/clinchem.2012.199711.
50. Choi, D.S., Park, J.O., Jang, S.C., Yoon, Y.J., Jung, J.W., Choi, D.Y., Kim, J.W., Kang, J.S., Park, J., Hwang, D., Lee, K.H., Park, S.H., Kim, Y.K., Desiderio, D.M., Kim, K.P., Gho, Y.S., Proteomic analysis of microvesicles derived from human colorectal cancer ascites. Proteomics 11 (2011), 2745–2751, 10.1002/pmic.201100022.
51. D'Souza-Schorey, C., Chavrier, P., ARF proteins: roles in membrane traffic and beyond. Nat. Rev. Mol. Cell Biol. 7 (2006), 347–358.
52. Muralidharan-Chari, V., Clancy, J., Plou, C., Romao, M., Chavrier, P., Raposo, G., D'Souza-Schorey, C., ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr. Biol. 19 (2009), 1875–1885, 10.1016/j.cub.2009.09.059.
53. Dolo, V., D'Ascenzo, S., Violini, S., Pompucci, L., Festuccia, C., Ginestra, A., Vittorelli, M.L., Canevari, S., Pavan, A., Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin. Exp. Metastasis 17 (1999), 131–140.
54. Valenti, R., Huber, V., Lero, M., Filipazzi, P., Parmiani, G., Rivoltini, L., Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res. 67 (2007), 2912–2915.
55. Jung, T., Castellana, D., Klingbeil, P., Hernandez, I.C., Vitacolonna, M., Orlicky, D.J., Roffler, S.R., Brodt, P., Zöller, M., CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia 11 (2009), 1093–1105.
56. Alderton, G.K., Exosomes drive pre-metastatic niche formation. Nat. Rev. Cancer, 12, 2012, 447, 10.1038/nrc3304.
57. Kosaka, N., Iguchi, H., Hagiwara, K., Yoshioka, Y., Takeshita, F., Ochiya, T., Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J. Biol. Chem. 288 (2013), 10849–10859.
58. Dayan, D., Salo, T., Salo, S., Nyberg, P., Nurmenniemi, S., Costea, D.E., Vered, M., Molecular crosstalk between cancer cells and tumor microenvironment components suggests potential targets for new therapeutic approaches in mobile tongue cancer. Cancer Med. 1 (2012), 128–140.
59. Luga, V., Wrana, J.L., Tumor-stroma interaction: revealing fibroblast-secreted exosomes as potent regulators of Wnt-planar cell polarity signaling in cancer metastasis. Cancer Res. 73 (2013), 6843–6847, 10.1158/0008-5472.CAN-13-1791.
60. Wang, H., Rana, S., Giese, N., Buechler, M.W., Zoeller, M., TSPAN8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells. Int. J. Cancer 133 (2013), 416–426, 10.1002/ijc.28044.
61. Wang, X., Ding, X., Nan, L., Wang, Y., Wang, J., Yan, Z., Zhang, W., Sun, J., Zhu, W., Ni, B., Dong, S., Yu, L., Investigation of the roles of exosomes in colorectal cancer liver metastasis. Oncol. Rep. 33 (2015), 2445–2453, 10.3892/or.2015.3843.
62. Holzner, S., Senfter, D., Stadler, S., Staribacher, A., Nguen, C.H., Gaggl, A., Geleff, S., Huttary, N., Krieger, S., Jäger, W., Dolznig, H., Mader, R.M., Krupitza, G., Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitro. Oncol. Rep. 36 (2016), 3065–3071, 10.3892/or.2016.5114.
63. Shen, B., Wu, N., Yang, J.M., Gould, S.J., Protein targeting to exosomes/microvesicles by plasma membrane anchors. J. Biol. Chem. 286 (2011), 14383–14395, 10.1074/jbc.M110.208660.
64. Fujita, M., Kinoshita, T., GPI-anchor remodelling: potential functions of GPI-anchors in intracellular trafficking and membrane dynamics. Biochem. Biophys. Acta 1821 (2012), 1050–1058, 10.1016/j.bbalip.2012.01.004.
65. Bolukbasi, M.F., Mizrak, A., Ozdener, G.B., Madlener, S., Strobel, T., Erkan, E.P., Fan, J.B., Breakefield, X.O., Saydam, O., miR-1289 and “Zip-code”-like sequence enrich mRNAs in microvesicles. Mol. Ther. Nucleic Acids, 1, 2012, e10, 10.1038/mtna.2011.2.
66. Uratani, R., Toiyama, Y., Kitajima, T., Kawamura, M., Hiro, J., Kobayashi, M., Tanaka, K., Inoue, Y., Mohri, Y., Mori, T., Kato, T., Goel, A., Kusunoki, M., Diagnostic potential of cell-free and exosomal microRNAs in the identification of patients with high-risk colorectal adenomas. PLoS One, 11, 2016, e0160722, 10.1371/journal.pone.0160722.
67. Matsumura, T., Sugimachi, K., Iinuma, H., Takahashi, Y., Kurashuige, J., Sawada, G., Ueda, M., Uchi, R., Ueo, H., Takano, Y., Shinden, Y., Eguchi, H., Yamamoto, H., Doki, Y., Mori, M., Ochiya, T., Mimori, K., Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer. Br. J. Cancer 113 (2015), 275–281, 10.1038/bjc.2015.201.
68. Ogata-Kawata, H., Izumiya, M., Kurioka, D., Honma, Y., Yamada, Y., Furuta, K., Gunji, T., Ohta, H., Okamoto, H., Sonoda, H., Watanabe, M., Nakagama, H., Yokota, J., Kohno, T., Tsuchiya, N., Circulating exosomal microRNA as biomarkers of colon cancer. PLoS One, 9, 2014, e92921, 10.1371/journal.pone.0092921.
69. Yoshioka, Y., Kosaka, N., Konishi, Y., Ohta, H., Okamoto, H., Sonoda, H., Nonaka, R., Yamamoto, H., Ishii, H., Mori, M., Furuta, K., Nakajima, T., Hayashi, H., Sugisaki, H., Higashimoto, H., Kato, T., Takeshita, F., Ochiya, T., Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nat. Commun., 5, 2014, 3591, 10.1038/ncomms4591.
70. Silva, J., Garcia, V., Rodriguez, M., Compte, M., Cisneros, E., Veguillas, P., Garcia, J.M., Dominguez, G., Campos-Martin, Y., Cuevas, J., Peña, C., Herrera, M., Diaz, R., Mohammed, N., Bonilla, F., Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosom. Cancer 51 (2012), 409–418.
71. Huber, V., Fais, S., Iero, M., Lugini, L., Canese, P., Squarcina, P., Zaccheddu, A., Colone, M., Arancia, G., Gentile, M., Seregni, E., Valenti, R., Ballabio, G., Belli, F., Leo, E., Parmiani, G., Rivoltini, L., Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology 128 (2005), 1796–1804.
72. Huang, Z., Zhu, D., Wu, L., He, M., Zhou, X., Zhang, L., Zhang, H., Wang, W., Zhu, J., Cheng, W., Chen, Y., Fan, Y., Qi, L., Yin, Y., Zhu, W., Shu, Y., Liu, P., Six serum miRNAs as potential diagnostic biomarkers for gastric cancer. Cancer Epidemiol. Biomark. Prev., Oct 18 2016 (pii: cebp.0607.2016).
73. Tokuhisa, M., Ichikawa, Y., Kosaka, N., Ochiya, T., Yashiro, M., Hirakawa, K., Kosaka, T., Makino, H., Akiyama, H., Kunisaki, C., Endo, I., Exosomal miRNAs from peritoneum lavage fluid as potential biomarkers of peritoneal metastasis in gastric cancer. PLoS One, 10, 2015, e0130472, 10.1371/journal.pone.0130472.
74. Li, Q., Shao, Y., Zhang, X., Zheng, T., Miao, M., Qin, L., Zhang, W., Wu, Y.L., Chen, L., Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer. Tumor Biol. 36 (2015), 2007–20012, 10.1007/s13277-014-2807-y.
75. Zhou, X., Zhu, W., Li, H., Wen, W., Cheng, W., Wang, F., Wu, Y., Qi, L., Fan, Y., Chen, Y., Ding, Y., Xu, J., Qian, J., Huang, Z., Wang, T., Zhu, D., Shu, Y., Liu, P., Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis. Sci Rep, 5, 2015, 11251, 10.1038/srep11251.
76. Zhong, H., Yang, Y., Ma, S., Xiu, F., Cai, Z., Zhao, H., Du, L., Induction of a tumour-specific CTL response by exosomes isolated from heat-treated malignant ascites of gastric cancer patients. Int. J. Hyperth. 27 (2011), 604–611, 10.3109/02656736.2011.564598.
77. Junguera, C., Castiella, T., Munoz, G., Fernandez-Pacheco, R., Luesma, M.J., Monzon, M., Biogenesis of a new type of extracellular vesicles in gastrointestinal stromal tumors: ultrastructural profiles of spherosomes. Histochem. Cell Biol. 146 (2016), 557–567.
78. Huang, Y.K., Yu, J.C., Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: an update and review. World J. Gastroenterol. 21 (2015), 9717–9726, 10.3748/wjg.v21.i33.9717.
79. Liao, J., Liu, R., Shi, Y.J., Yin, L.H., Pu, Y.P., Exosome-shuttling micro-RNA-21 promotes cell migration and invasion-targeting PDCD4 in esophageal cancer. Int. J. Oncol. 48 (2016), 2567–2579, 10.3892/ijo.2016.3453.
80. Matsumoto, Y., Kano, M., Akutsu, Y., Hanari, N., Hoshino, I., Murakami, K., Usui, A., Suito, H., Takahashi, M., Otsuka, R., Xin, H., Komatsu, A., Iida, K., Matsubara, H., Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma. Oncol. Rep. 36 (2016), 2535–2543, 10.3892/or.2016.5066.
81. Chiam, K., Wang, T., Watson, D.L., Mayne, G.C., Irvine, T.S., Bright, T., Smith, L., White, I.A., Bowen, J.M., Keefe, D., Thompson, S.K., Jones, M.E., Hussey, D.J., Circulating serum exosomal miRNAs as potential biomarkers for esophageal adenocarcinoma. J. Gastrointest. Surg. 19 (2015), 1208–1215, 10.1007/s11605-015-2829-9.
82. Warnecke-Eberz, U., Chon, S.-H., Hoelscher, A.H., Drebber, U., Bollschweiler, E., Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor. Tumor Biol. 36 (2015), 4643–4653, 10.1007/s13277-015-3112-0.
83. Tanaka, Y., Kamohara, H., Kinoshita, K., Kurashige, J., Ishimoto, T., Iwatsuki, M., Watanabe, M., Baba, H., Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. Cancer 119 (2013), 1159–1167, 10.1002/cncr.27895.
84. Bobryshev, Y.V., Killingsworth, M.C., Lord, R.V., Structural alterations of the mucosa stroma in the Barrett's esophagus metaplasia-dysplasia-adenocarcinoma sequence. J. Gastroenterol. Hepatol. 27 (2012), 1498–1504.
85. Campanella, C., Rappa, F., Sciume, C., Marino Gammaza, A., Barone, R., Bucchieri, F., David, S., Curcurù, G., Caruso Bavisotto, C., Pitruzzella, A., Geraci, G., Modica, G., Farina, F., Zummo, G., Fais, S., Conway de Macario, E., Macario, A.J., Cappello, F., Heat shock protein 60 levels in tissue and circulating exosomes in human large bowel cancer before and after ablative surgery. Cancer 121 (2015), 3230–3239, 10.1002/cncr.29499.
86. Lai, X., Wang, M., Deitz McElyea, S., Sherman, S., House, M., Korc, M., A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer. Cancer Lett. 393 (2017), 86–93.
87. San Lukas, F.A., Allenson, K., Bernard, V., Castillo, J., Kim, D.U., Ellis, K., Ehli, E.A., Davies, G.E., Petersen, J.L., Li, D., Wolff, R., Katz, M., Varadhachary, G., Wistuba, L., Maitra, A., Alvarez, H., Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes. Ann. Oncol. 27 (2016), 635–641, 10.1093/annonc/mdv604.
88. Costa-Silva, B., Aiello, N.M., Ocean, A.J., Singh, S., Zhang, H., Thakur, B.K., Becker, A., Hoshino, A., Mark, M.T., Molina, H., Xiang, J., Zhang, T., Theilen, T.M., García-Santos, G., Williams, C., Ararso, Y., Huang, Y., Rodrigues, G., Shen, T.L., Labori, K.J., Lothe, I.M., Kure, E.H., Hernandez, J., Doussot, A., Ebbesen, S.H., Grandgenett, P.M., Hollingsworth, M.A., Jain, M., Mallya, K., Batra, S.K., Jarnagin, W.R., Schwartz, R.E., Matei, I., Peinado, H., Stanger, B.Z., Bromberg, J., Lyden, D., Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat. Cell Biol. 17 (2015), 816–826, 10.1038/ncb3169.
89. Javeed, N., Sagar, G., Dutta, S.K., Smyrk, T.C., Lau, J.S., Bhattacharya, S., Truty, M., Petersen, G.M., Kaufman, R.J., Chari, S.T., Mukhopadhyay, D., Pancreatic cancer-derived exosomes cause paraneoplastic β-cell dysfunction. Clin. Cancer Res. 21 (2015), 1722–1733, 10.1158/1078-0432.CCR-14-2022.
90. Joshi, G.K., Deitz-McElyea, S., Liyanage, T., Lawrence, K., Mali, S., Sardar, R., Korc, M., Label-free nanoplasmonic-based short noncoding RNA sensing at attomolar concentrations allows for quantitative and highly specific assay of microRNA-10b in biological fluids and circulating exosomes. ACS Nano 9 (2015), 11075–11089, 10.1021/acsnano.5b04527.
91. Melo, S.A., Luecke, L.B., Kahlert, C., Fernandez, A.F., Gammon, S.T., Kaye, J., LeBleu, V.S., Mittendorf, V.S., Weitz, J., Rahbari, N., Reissfelder, C., Pilarsky, C., Fraga, M.F., Piwnica-Worms, D., Kalluri, R., Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523 (2015), 177–182, 10.1038/nature14581.
92. Kanwar, S.S., Dunlay, C.J., Simeone, D.M., Nagrath, S., Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip 14 (2014), 1891–1900, 10.1039/c4lc00136b.
93. Madhavan, B., Yue, S., Galli, U., Rana, S., Gross, W., Müller, M., Giese, N.A., Kalthoff, H., Becker, T., Büchler, M.W., Zöller, M., Combined evalustion of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer increases sensitivity and specificity. Int. J. Cancer 136 (2015), 2616–2627, 10.1002/ijc.29324.
94. Que, R., Ding, G., Chen, J., Cao, L., Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma. World J. Surg. Oncol., 11, 2013, 219, 10.1186/1477-7819-11-219.
95. Willms, A., Mueller, C., Julich, H., Klein, N., Schwab, R., Guesgen, C., Richardsen, I., Schaaf, S., Krawczyk, M., Krawczyk, M., Lammert, F., Schuppan, D., Lukacs-Kornek, V., Kornek, M., Tumour-associated circulating microparticles: a novel liquid biopsy tool for screening and therapy monitoring of colorectal carcinoma and other epithelial neoplasia. Oncotarget 7 (2016), 30867–30875, 10.18632/oncotarget.9018.
96. Mege, D., Panicot-Dubois, L., Ouaissi, M., Robert, S., Sielezneff, I., Sastre, B., Dignat-George, F., Dubois, C., The origin and concentration of circulating microparticles differ according to cancer type and evolution: a prospective single-center study. Int. J. Cancer 13894 (2016), 939–948, 10.1002/ijc.29837.
97. Yamada, N., Tsujimura, N., Kumazaki, M., Shinohara, H., Taniguchi, K., Nakagawa, Y., Naoe, T., Akao, Y., Colorectal cancer cell-derived microvesicles containing microRNA-1246 promote angiogenesis by activating Smad 1/5/8 signaling elicited by PML down-regulation in endothelial cells. Biochim. Biophys. Acta 1839 (2014), 1256–1272, 10.1016/j.bbagrm.2014.09.002.
98. Ogorevc, E., Stukelj, R., Bedina-Zavec, A., Sustar, V., Simundic, M., Kralj-Iglic, V., Jansa, R., A 32-month follow-up study of nanovesicle concentrations in blood from 12 patients with gastrointestinal stromal tumour treated with imatinib. Biochem. Soc. Trans. 41 (2013), 303–308, 10.1042/BST20120247.
99. Stec, M., Szatanek, R., Baj-Kryworzeka, M., Baran, J., Zembala, M., Barbasz, J., Waligórska, A., Dobrucki, J.W., Mytar, B., Szczepanik, A., Siedlar, M., Drabik, G., Urbanowicz, B., Zembala, M., Interactions of tumour-derived micro(nano)vesicles with human gastric cancer cells. J. Transl. Med., 13, 2015, 376, 10.1186/s12967-015-0737-0.
100. Mrvar-Brecko, A., Sustar, V., Jansa, V., Stukelj, R., Jansa, R., Mujagic, E., Kruljc, P., Iglic, A., Hagerstrand, H., Kralj-Iglic, V., Isolated microvesicles from peripheral blood and body fluids as observed by scanning electron microscope. Blood Cells Mol. Dis. 44 (2010), 307–312.
101. Hron, G., Kollars, M., Weber, H., Sagaster, V., Quehenberger, P., Eichinger, S., Kyrle, P.A., Weltermann, A., Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb. Haemost. 97 (2007), 119–123.
102. Yang, C., Ma, R., Jiang, T., Cao, M., Zhao, L., Bi, Y., Kou, J., Shi, J., Zou, X., Contributions of phosphatidylserine-positive platelets and leukocytes and microparticles to hypercoagulable state in gastric cancer patients. Tumour Biol. 37 (2016), 7881–7891, 10.1007/s13277-015-4667-5.
103. Baran, J., Baj-Krzyworzeka, M., Weglarczyk, K., Szatanek, R., Zembala, M., Barbasz, J., Czupryna, A., Szczepanik, A., Zembala, M., Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol. Immunother. 59 (2010), 841–850, 10.1007/s00262-009-0808-2.
104. Jansa, R., Sustar, V., Frank, M., Susanj, P., Bester, J., Mancek-Keber, M., Krzan, M., Iglic, A., Number of microvesicles in peripheral blood and ability of plasma to induce adhesion between phospholipid membranes in 19 patients with gastrointestinal diseases. Blood Cells Mol. Dis. 41 (2008), 124–132, 10.1016/j.bcmd.2008.01.009.
105. Kim, H.K., Song, K.S., Park, Y.S., Kang, Y.H., Lee, Y.J., Lee, K.R., Kim, H.K., Ryu, K.W., Bae, J.M., Kim, S., Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur. J. Cancer 39 (2003), 184–191.
106. Geddings, J.E., Hisada, Y., Boulaftali, Y., Getz, T.M., Whelihan, M., Fuentes, R., Dee, R., Cooley, B.C., Key, N.S., Wolberg, A.S., Bergmeier, W., Mackman, N., Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice. J. Thromb. Haemost. 14 (2016), 153–166, 10.1111/jth.13181.
107. Woei-A-Jin, F.J., Tesselaar, M.E., Garcia Rodriguez, P., Romijn, F.P., Bertina, R.M., Osanto, S., Tissue factor-bearing microparticles and CA19.9: two players in pancreatic cancer-associated thrombosis. Br. J. Cancer 115 (2016), 332–338, 10.1038/bjc.2016.170.
108. Thomas, G.M., Brill, A., Mezouar, S., Crescence, L., Gallant, M., Dubois, C., Wagner, D.D., Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice. J. Thromb. Haemost. 13 (2015), 1310–1319, 10.1111/jth.13002.
109. Bigagli, E., Luceri, C., Guasti, D., Cinci, L., Exosomes secreted from human colon cancer cells influence the adhesion of neighbouring metastatic cells: role of microRNA-210. Cancer Biol. Ther. 11 (2016), 1–8.
110. Chiba, M., Watanabe, N., Watanabe, M., Sakamoto, M., Sato, A., Fujisaki, M., Kubota, S., Monzen, S., Maruyama, A., Nanashima, N., Kashiwakura, I., Nakamura, T., Exosomes derived from SW480 colorectal cancer cells promote cell migration in HepG2 hepatocellular cancer cells via the mitogen-activated protein kinase pathway. Int. J. Oncol. 48 (2016), 305–312.
111. Oleksiuk, O., Abba, M., Tezcan, K.C., Schaufler, W., Bestwater, F., Patil, N., Birk, U., Hafner, M., Altevogt, P., Cremer, C., Allgayer, H., Single-molecule localization microscopy allows for the analysis of cancer metastasis-specific miRNA distribution on the nanoscale. Oncotarget 6 (2015), 44745–44757, 10.18632/oncotarget.6297.
112. Wang, Z., von Au, A., Schnoelzer, M., Hackert, T., Zoeller, M., CD44v6-competent tumor exosomes promote motility, invasion and cancer-initiating cell marker expression in pancreatic and colorectal cancer cells. Oncotarget 7 (2016), 55409–55436, 10.18632/oncotarget.10580.
113. Xu, R., Greening, D.W., Rai, A., Ji, H., Simpson, R.J., Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. Methods 87 (2015), 11–25.
114. Zhu, Y., Chen, X., Pan, Q., Wang, Y., Su, C., Jiang, Li, Y., Xu, N., Wu, L., Lou, X., Liu, S., A comprehensive proteomics analysis reveals a secretory path- and status-dependent signature of exosomes released of tumor-associated macrophages. J. Proteome Res. 14 (2015), 4319–4331, 10.1021/acs.jproteome.5b00770.
115. Akao, Y., Khoo, F., Kumazaki, M., Shinohara, H., Miki, K., Yamada, N., Extracellular disposal of tumor-suppressor miRs-145 and -34a via microvesicles and 5-FU resistance of human colon cancer cells. Int. J. Mol. Sci. 15 (2014), 1392–1401, 10.3390/ijms15011392.
116. Ji, H., Chen, M., Greening, D.W., He, W., Rai, A., Zhang, W., Simpson, R.J., Deep sequencing of RNA from three different extracellular vesicle subtypes (RV) subtypes released freom the human LIM1863 colon cancer cwell line uncovers distinct miRNA-enrichment signatures. PLoS One, 9, 2014, e110314, 10.1371/journal.pone.0110314.
117. Soldevilla, B., Rodriguez, M., San Millan, C., Garcia, V., Fernandez-Perianez, R., Gil-Calderón, B., Martín, P., García-Grande, A., Silva, J., Bonilla, F., Domínguez, G., Tumor-derived exosomes are enriched in ΔNp73, which promotes oncogenic potential in acceptor cells and correlates with patients survival. Hum. Mol. Genet. 23 (2014), 467–478, 10.1093/hmg/ddt437.
118. Bernhard, O.K., Greening, D.W., Barnes, T.W., Ji, H., Simpson, R.J., Detection of cadherin-17 in human colon cancer LIM 1215 cell secretome and tumour xenograft-derived interstitial liquid and plasma. Biochim. Biophys. Acta 2013 (1834), 2372–2379, 10.1016/j.bbapap.2013.03.022.
119. Hong, B.S., Cho, J.H., Kim, H., Choi, E.J., Rho, S., Kim, J., Kim, J.H., Choi, D.S., Kim, Y.K., Hwang, D., Gho, Y.S., Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genomics, 10, 2009, 556, 10.1186/1471-2164-10-556.
120. Muturi, H.T., Dreesen, J.D., Nilewski, E., Jastrow, H., Giebel, B., Ergun, S., Singer, B.B., Tumor and endothelial cell-derived microvesicles carry distinct CEACAMs and influence T-cell behavior. PLoS One, 8, 2013, e74654, 10.1371/journal.pone.0074654.
121. Tauro, B.J., Greening, D.W., Mathias, R.A., Mathivanan, S., Ji, H., Simpson, R.J., Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. Mol. Cell. Proteomics 12 (2013), 587–598, 10.1074/mcp.M112.021303.
122. Chiba, M., Kimura, M., Asari, S., Exosomes secreted from human colorectal cancer cell lines contain mRNAs, microRNAs and natural antisense RNAs, that can transfer into the human hepatoma HepG2 and lung cancer A549 cell lines. Oncol. Rep. 28 (2012), 1551–1558.
123. Choi, D.S., Choi, D.Y., Hong, B.S., Jang, S.C., Kim, D.K., Lee, J., Kim, Y.K., Kim, K.P., Gho, Y.S., Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells. J. Extracell. Vesicles, 1, 2012, 10.3402/jev.v1i0.18704.
124. Klein-Scory, S., Tehrani, M.M., Eilert-Micus, C., Adamczyk, K.A., Wojtalewicz, N., Schnölzer, M., Hahn, S.A., Schmiegel, W., Schwarte-Waldhoff, I., New insights in the composition of extracellular vesicles from pancreatic cancer cells: implications for biomarkers and functions. Proteome Sci., 12, 2014, 50, 10.1186/s12953-014-0050-5.
125. Mathivanan, S., Lim, J.W.E., Tauro, B.J., Moritz, R.L., Simpson, R.J., Proteomics analysis of A33 immunoaffinity-purified exosomes released from human colon tumor cell line LIM215 reveals a tissue-specific protein signature. Mol. Cell. Proteomics 9 (2010), 197–208, 10.1074/mcp.M900152-MCP200.
126. Gastpar, R., Gehrmann, M., Bausero, M.A., Asea, A., Gross, C., Schroeder, J.A., Multhoff, G., Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res. 65 (2005), 5238–5247.
127. van Niel, G., Raposo, G., Candalh, C., Boussac, M., Hershberg, R., Cerf-Bensussan, N., Heyman, M., Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 121 (2001), 337–349.
128. Liao, J., Liu, R., Yin, L., Pu, Y., Expression profiling of exosomal miRNAs derived from human esophageal cancer cells by Solexa high-throughput sequencing. Int. J. Mol. Sci. 15 (2014), 15530–15551, 10.3390/ijms150915530.
129. Nouraee, N., Khazaei, S., Vasei, M., Razavipour, S.F., Sadeghizadeh, M., Mowia, S.J., MicroRNA contribution in tumor microenvironment of esophageal cancer. Cancer Biomark. 16 (2016), 367–376, 10.3233/CBM-160575.
130. Takeshita, N., Hoshino, I., Mori, M., Akutsu, Y., Yoneyama, Y., Ikeda, N., Isozaki, Y., Maruyama, T., Akanuma, N., Komatsu, A., Jitsukawa, M., Matsubara, H., Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophagal squamous cell carcinoma. Br. J. Cancer 108 (2013), 644–652, 10.1038/bjc.2013.8.
131. Watson, G.A., Naran, S., Zhang, X., Stang, M.T., Queiroz de Oliveira, P.E., Hughes, S.J., Cytoplasmic overexpression of CD95L in esophageal adenocarcinoma cells overcomes resistance to CD95-mediated apoptosis. Neoplasia 13 (2011), 198–205.
132. Wu, C.W., Ng, S.S., Dong, Y.J., Ng, S.C., Leungm, W.W., Lee, C.W., Wong, Y.N., Chan, F.K., Yu, J., Sung, J.J., Detection of miR-92a and miR-32 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut 61 (2012), 739–745, 10.1136/gut.2011.239236.
133. Zhang, H., Bai, M., Deng, T., Liu, R., Wang, X., Qu, Y., Duan, J., Zhang, L., Ning, T., Ge, S., Li, H., Zhou, L., Liu, Y., Huang, D., Ying, G., Ba, Y., Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma. Cancer Lett. 375 (2016), 331–339, 10.1016/j.canlet.2016.03.026.
134. Anami, K., Oue, N., Noguchi, T., Sakamoto, N., Sentani, K., Hayashi, T., Naito, Y., Oo, H.Z., Yasui, W., TSPAN8, identified by Escherichia coli ampicillin secretion trap, is associated with cell growth and invasion in gastric cancer. Gastric Cancer 19 (2016), 370–380.
135. Li, C., Liu, D.-R., Li, G.-G., Wang, H.-H., Li, X.-W., Zhang, W., Wu, Y.L., Chen, L., CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway. World J. Gastroenterol. 21 (2015), 6215–6228, 10.3748/wjg.v21.i20.621-28 (doi: 10.3748/wjg.v21.i20.6215).
136. Ohshima, K., Kanto, K., Hatakeyama, K., Ide, T., Wakabayashi-Nakao, K., Watanabe, Y., Sakura, N., Terashima, M., Yamaguchi, K., Mochizuki, T., Exosome-mediated extracellular release of polyadenylate-binding protein 1 in human metastatic duodenal cancer cells. Proteomics 14 (2014), 2297–2306, 10.1002/pmic.201300477.
137. Wang, M., Zhao, C., Shi, H., Zhang, B., Zhang, L., Zhang, X., Wang, S., Wu, X., Yang, T., Huang, F., Cai, J., Zhu, Q., Zhu, W., Qian, H., Xu, W., Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer. Br. J. Cancer 110 (2014), 1199–1210, 10.1038/bjc.2014.14.
138. Gu, J., Qian, H., Shen, L., Zhang, X., Zhu, W., Huang, L., Yan, Y., Mao, F., Zhao, C., Shi, Y., Xu, W., Gastric cancer exosomes trigger differentiation of umbilical cord derived mesenchymal stem cells to carcinoma-associated fibroblasts through TGF-beta/Smad pathway. PLoS One, 7, 2012, e52465, 10.1371/journal.pone.0052465.
139. Ohsima, K., Inoue, K., Fujiwara, A., Hatakeyama, K., Kanto, K., Watanabe, Y., Muramatsu, K., Fukuda, Y., Ogura, S., Yamaguchi, K., Mochizuki, T., Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One, 5, 2010, e13247, 10.1371/journal.pone.0013247.
140. Qu, J.L., Qu, X.J., Zhao, M.F., Teng, Y.E., Zhang, Y., Hou, K.Z., Jiang, Y.H., Yang, X.H., Liu, Y.P., Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK. Dig. Liver Dis. 41 (2009), 875–880, 10.1016/j.dld.2009.04.006.
141. Takikawa, T., Masamune, A., Yoshida, N., Hamada, S., Kogure, T., Shimosegawa, T., Exosomes derived from pancreatic stellate cells: microRNA signature and effects on pancreatic cancer cells. Pancreas 46 (2017), 19–27.
142. Sagar, G., Sah, R.P., Javeed, N., Dutta, S.K., Smyrk, T.C., Lau, J.S., Giorgadze, N., Tchkonia, T., Kirkland, J.L., Chari, S.T., Mukhopadhyay, D., Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue. Gut 65 (2016), 1165–1174, 10.1136/gutjnl-2014-308350.
143. Ding, G., Zhou, L., Qian, Y., Fu, M., Chen, J., Chen, J., Xiang, J., Wu, Z., Jiang, G., Cao, L., Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p. Oncotarget 6 (2015), 29877–29888, 10.18632/oncotarget.4924.
144. Osterman, C.J.D., Lynch, J.C., Leaf, P., Gonda, A., Bennit, H.R.F., Griffiths, D., Wall, N.R., Circumin modulates pancreatic adenocarcinoma cell-derived exosomal function. PLoS One, 10, 2015, e0132845, 10.1371/journal.pone.0132845.
145. Pang, W., Su, J., Wang, Y., Feng, H., Dai, X., Yuan, Y., Chen, X., Yao, W., Pancreatic cancer-secreted miR-155 implicates in the conversion from normal fibroblasts to cancer-associated fibroblasts. Cancer Sci. 106 (2015), 1362–1369, 10.1111/cas.12747.
146. Klein-Scory, S., Kuebler, S., Diehl, H., Eilert-Micus, C., Reinacher-Schick, A., Stühler, K., Warscheid, B., Meyer, H.E., Schmiegel, W., Schwarte-Waldhoff, I., Immunoscreening of the extracellular proteome of colorectal cancer cells. BMC Cancer, 10, 2010, 70, 10.1186/1471-2407-10-70.
147. Zhou, M., Chen, J., Zhou, L., Chen, W., Ding, G., Cao, L., Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203. Cell. Immunol. 292 (2014), 65–69, 10.1016/j.cellimm.2014.09.004.
148. Lau, C., Kim, Y., Chia, D., Spielmann, N., Eibl, G., Elashoff, D., Wie, F., Lin, Y.L., Moro, A., Grogan, T., Chiang, S., Feinstein, E., Schafer, C., Farrell, J., Wong, D.T., Role of pancreatic cancer-derived exosomes in salivary biomarker development. J. Biol. Chem. 288 (2013), 26888–26897, 10.1074/jbc.M113.452458.
149. Adamczuk, K.A., Klein-Scory, S., Yehrani, M.M., Warnken, U., Schmiegel, W., Schnölzer, M., Schwarte-Waldhoff, I., Characterization of soluble and exosomal forms of the EGFR released from pancreatic cancer cells. Life Sci. 89 (2011), 304–312, 10.1016/j.lfs.2011.06.020.
150. Ristorcelli, E., Beraud, E., Verrando, P., Villard, C., Lafitte, D., Sbarra, V., Lombardo, D., Verine, A., Human tumor nanoparticles induce apoptosis of pancreatic cancer cells. FASEB J. 22 (2008), 3358–3369, 10.1096/fj.07-102855.
151. Polyak, K., Tumor heterogeneity confounds and illuminates: a case for Darwinian tumor evolution. Nat. Med. 20 (2014), 344–346, 10.1038/nm.3518.
152. Alizadeh, A.A., Aranda, V., Bardelli, A., Blanpain, C., Bock, C., Borowski, C., Caldas, C., Califano, A., Doherty, M., Elsner, M., Esteller, M., Fitzgerald, R., Korbel, J.O., Lichter, P., Mason, C.E., Navin, N., Pe'er, D., Polyak, K., Roberts, C.W., Siu, L., Snyder, A., Stower, H., Swanton, C., Verhaak, R.G., Zenklusen, J.C., Zuber, J., Zucman-Rossi, J., Towards understanding and exploiting tumor heterogeneity. Nat. Med. 21 (2015), 846–853, 10.1038/nm.3915.
153. Zomer, A., van Rheenen, J., Implications of extracellular vesicle transfer on cellular heterogeneity in cancer: what are potential clinical ramnifications?. Cancer Res. 76:8 (2016), 2071–2075, 10.1158/0008-5472.CAN-15-2804.
154. Hunter, M.P., Ismail, N., Zhang, X., Aguda, B.D., Lee, E.J., Yu, L., Xiao, T., Schafer, J., Lee, M.L., Schmittgen, T.D., Nana-Sinkam, S.P., Jarjoura, D., Marsh, C.B., Detection of microRNA expression in human peripheral blood microvesicles. PLoS One, 3, 2008, e3694, 10.1371/journal.pone.0003694.
155. van Balcom, B.W., Eisele, A.S., Pegtel, D.M., Bervoets, S., Verhaar, M.C., Quantitative and qualitative analysis of small RNAs in human ensothelial cells and exosomes provides insights into localized RNA processing, degradation and sorting. J. Extracel. Vesicles, 4, 2015, 26760, 10.3402/jev.v4.26760.
156. Mohankumar, S., Patel, T., Extracellular vesicle long noncoding RNA as potential biomarkers of liver cancer. Brief. Funct. Genomic. 15 (2016), 249–256, 10.1093/bfgp/elv058.
157. Cho, W.C., OncomiRs: the discovery and progress of microRNAs in cancers. Mol. Cancer, 6, 2007, 60.
158. Luo, X., Burwinkel, B., Tao, S., Brenner, H., MicroRNA signatures: novel biomarker for colorectal cancer?. Cancer Epidemiol. Biomark. Prev. 20 (2011), 1272–1286.
159. Goldie, B.J., Dun, M.D., Lin, M., Smith, N.D., Verrils, N.M., Dayas, C.V., Cairns, M.J., Activity-associated miRNA are packaged in Map1b-enriched exosomes released from depolarized neurons. Nucleic Acids Res. 42 (2014), 9195–9208, 10.1093/nar/gku594.
160. Patton, J.G., Franklin, J.L., Weaver, A.M., Vickers, K., Zhang, B., Coffey, R.J., Ansel, K.M., Blelloch, R., Goga, A., Huang, B., L'Etoille, N., Raffai, R.L., Lai, C.P., Krichevsky, A.M., Mateescu, B., Greiner, V.J., Hunter, C., Voinnet, O., McManus, M.T., Biogenesis, delivery, and function of extracellular RNA. J. Extracell. Vesicles, 4, 2015, 27494, 10.3402/jev.v4.27494.
161. Zhang, J., Li, S., Li, L., Li, M., Guo, C., Yao, J., Mi, S., Exosome and exosomal microRNA: trafficking, sorting and function. Genomics Proteomics Bioinformatics 13 (2015), 17–24, 10.1016/j.gpb.2015.02.001.
162. Villarroya-Beltri, C., Gutierrez-Vazquez, C., Sanchez-Cabo, F., Perez-Hernandez, D., Vázquez, J., Martin-Cofreces, N., Martinez-Herrera, D.J., Pascual-Montano, A., Mittelbrunn, M., Sánchez-Madrid, F., Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat. Commun., 4, 2013, 2980, 10.1038/ncomms3980.
163. Koppers-Lalic, D., Hackenberg, M., Bijnsdorp, I.V., van Eijndhoven, M.A., Sadek, P., Sie, D., Zini, N., Middeldorp, J.M., Ylstra, B., de Menezes, R.X., Würdinger, T., Meijer, G.A., Pegtel, D.M., Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes. Cell Rep. 8 (2014), 1649–1658, 10.1016/j.celrep.2014.08.027.
164. Cha, D.J., Franklin, J.L., Dou, Y., Liu, Q., Higginbotham, J.N., Demory Beckler, M., Weaver, A.M., Vickers, K., Prasad, N., Levy, S., Zhang, B., Coffey, R.J., Patton, J.G., KRAS-dependent sorting of miRNA to exosomes. elife, 4, 2015, e07197, 10.7554/eLife.07197.
165. McKenzie, A.J., Hoshino, D., Hong, N.H., Cha, D.J., Franklin, J.L., Coffey, R.J., Patton, J.G., Weaver, A.M., KRAS-MEK signaling controls Ago2 sorting into exosomes. Cell Rep. 15 (2016), 978–987, 10.1016/j.celrep.2016.03.085.
166. Melo, S.A., Sugimoto, H., O'Connell, J.T., Kato, N., Villanueva, A., Vidal, A., Qiu, L., Vitkin, E., Perelman, L.T., Melo, C.A., Lucci, A., Ivan, C., Calin, G.A., Kalluri, R., Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell 26 (2014), 707–721, 10.1016/j.ccell.2014.09.005.
167. Squadrito, M.L., Baer, C., Burdet, F., Maderna, C., Gilfillan, G.D., Lyle, R., Ibberson, M., De Palma, M., Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells. Cell Rep. 8 (2014), 1432–1446, 10.1016/j.celrep.2014.07.035.
168. Shurtleff, M.J., Temoche-Diaz, M.M., Karfilis, K.V., Ri, S., Schekman, R., Y-box protein 1 is required to sort microRNAs into exosomes in cells and in cell-free reaction. elife, 5, 2016, e19276, 10.7554/eLife.19276 (pii: e19276).
169. Skog, J., Wurdinger, T., van Rijn, T.S., Meijer, D.H., Gainche, L., Sena-Esteves, M., Curry, W.T., Carter, B.S., Krichevsky, A.M., Breakefield, X.O., Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10 (2008), 1470–1476, 10.1038/ncb1800.
170. Mitchell, P.S., Parkin, R.K., Kroh, E.M., Fritz, B.R., Wyman, S.K., Pogosova-Agadjanyan, E.L., Peterson, A., Noteboom, J., O'Briant, K.C., Allen, A., Lin, D.W., Urban, N., Drescher, C.W., Knudsen, B.S., Stirewalt, D.L., Gentleman, R., Vessella, R.L., Nelson, P.S., Martin, D.B., Tewari, M., Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 10513–10518, 10.1073/pnas.0804549105.
171. Wu, L., Zhang, X., Zhang, B., Shi, H., Yuan, X., Sun, Y., Pan, Z., Qian, H., Xu, W., Exosomes derived from gastric cancer cells activate NF-kB in macrophages to promote cancer progression. Tumor Biol. 37 (2016), 12169–12180.
172. Thomas, J., Ohtsuka, M., Pichler, M., Ling, H., MicroRNAs: clinical relevance in colorectal cancer. Int. J. Mol. Sci. 16 (2015), 28063–28076, 10.3390/ijms161226080.
173. Yau, T.O., Wu, C.W., Tang, C.M., Chen, Y., Fang, J., Dong, Y., Liang, Q., Ng, S.S., Chan, F.K., Sung, J.J., Yu, J., MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer. Oncotarget 7 (2016), 1559–1568, 10.18632/oncotarget.6403.
174. Huang, Z., Huang, D., Ni, S., Peng, Z., Sheng, W., Du, X., Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer 127 (2010), 118–126, 10.1002/ijc.25007.
175. Ng, E.K., Chong, W.W., Jin, H., Lam, E.K., Shin, V.Y., Yu, J., Poon, T.C., Ng, S.S., Sung, J.J., Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58 (2009), 1375–1381, 10.1136/gut.2008.167817.
176. Pu, X.X., Huang, G.L., Guo, H.Q., Guo, C.C., Li, H., Ye, S., Ling, S., Jiang, L., Tian, Y., Lin, T.Y., Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J. Gastroenterol. Hepatol. 25 (2010), 1674–1680, 10.1111/j.1440-1746.2010.06417.x.
177. Yamada, N., Nakagawa, Y., Tsujimura, N., Kumazaki, M., Noguchi, S., Mori, T., Hirata, L., Maruo, K., Akao, Y., Role of intracellular and extracellular microRNA-92a in colorectal cancer. Transl. Oncol. 6 (2013), 482–492.
178. Dalmasso, G., Nguen, H.T., Yan, Y., Laroui, H., Charania, M.A., Ayyadurai, S., Sitaraman, S.V., Merlin, D., Microbiota modulate host gene expression via microRNAs. PLoS One, 6, 2011, e19293, 10.1371/journal.pone.0019293.
179. Taylor, D.D., Gercel-Taylor, C., MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 110 (2008), 13–21, 10.1016/j.ygyno.2008.04.033.
180. Tanaka, S., Hosokawa, M., Ueda, K., Iwakawa, S., Effects of decitabine on invasion and exosomal expression of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer. Biol. Pharm. Bull. 38 (2015), 1272–1279, 10.1248/bpb.b15-00129.
181. Choi, D.S., Yang, J.S., Choi, E.J., Jang, S.C., Park, S., Kim, O.Y., Hwang, D., Kim, K.P., Kim, Y.K., Kim, S., Gho, Y.S., The protein interaction network of extracellular vesicles derived from human colorectal cancer cells. J. Proteome Res. 11 (2012), 1144–1151, 10.1021/pr200842h.
182. Ghossoub, R., Lembo, F., Rubio, A., Gaillard, C.B., Bouchet, J., Vitale, N., Slavík, J., Machala, M., Zimmermann, P., Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2. Nat. Commun., 5, 2014, 3477, 10.1038/ncomms4477.
183. Xue, H., Lu, B., Zhang, J., Wu, M., Huang, Q., Wu, Q., Sheng, H., Wu, D., Hu, J., Lai, M., Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J. Proteome Res. 9 (2010), 545–555.
184. Ji, H., Greening, D.W., Barnes, T.W., Lim, J.W., Tauro, B.J., Rai, A., Xu, R., Adda, C., Mathivanan, S., Zhao, W., Xue, Y., Xu, T., Zhu, H.J., Simpson, R.J., Proteome profiling of exosomes derived from human and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components. Proteomics 13 (2013), 1672–1686.
185. DeRita, R.M., Zerlanko, B., Singh, A., Lu, H., Iozzo, R.V., Benovic, J.L., Languino, L.R., c-SRC, insulin-like growth factor I receptor, G-protein-coupled receptor kinases and focal adhesion kinase are enriched into prostate cancer cell exosomes. J. Cell. Biochem. 118 (2017), 66–73, 10.1002/jcb.25611.
186. Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brügger, B., Simons, M., Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319 (2008), 1244–1247, 10.1126/science.1153124.
187. Parolini, I., Federici, C., Raggi, C., Lugini, L., Palleschi, S., De Milito, A., Coscia, C., Iessi, E., Logozzi, M., Molinari, A., Colone, M., Tatti, M., Sargiacomo, M., Fais, S., Microenvironmental pH is a key factor for exosome traffic in tumor cells. J. Biol. Chem. 284 (2009), 34211–34222.
188. Subra, C., Laulagnier, K., Perret, B., Record, M., Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. Biochimie 89 (2007), 205–212.
189. Lydic, T.A., Townsend, S., Adda, C.G., Collins, C., Mathivanan, S., Reid, G.E., Rapid and comprehensive “shotgun” lipidome profiling of colorectal cancer cell derived exosomes. Methods 87 (2015), 83–95, 10.1016/j.ymeth.2015.04.014.
190. Beloribi, S., Ristorcelli, E., Breuzard, G., Silvy, F., Bertrand-Michel, J., Beraud, E., Verine, A., Lombardo, D., Exosomal lipids impact notch signaling and induce death of human pancreatic tumoral SOJ-6 cells. PLoS One, 7, 2012, e47480, 10.1371/journal.pone.0047480.
191. Haraszti, R.A., Didiot, M.C., Sapp, E., Leszyk, J., Shaffer, S.A., Rockwell, H.E., Gao, F., Narain, N.R., DiFiglia, M., Kiebish, M.A., Aronin, N., High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. J. Extracel. Vesicles, 5, 2016, 10.3402/jev.v5.32570.
192. Flynn, A.D., Yin, H., Lipid-targeting peptide probes for extracellular vesicles. J. Cell. Physiol. 231 (2016), 2327–2332, 10.1002/jcp.25354.
193. Carayon, K., Chaoui, K., Ronzier, E., Lazar, I., Bertrand-Michel, J., Roques, V., Balor, S., Terce, F., Lopez, A., Salomé, L., Joly, E., Proteolipidic composition of exosomes changes during reticulocyte maturation. J. Biol. Chem. 286 (2011), 34426–34439, 10.1074/jbc.
194. Llorente, A., Skotland, T., Sylvanne, T., Kauhanen, D., Rog, T., Orlowski, A., Vattulainen, I., Ekroos, K., Sandvig, K., Molecular lipidomics of exosomes released by PC-3 prostate cancer cells. Biochim. Biophys. Acta 1831 (2013), 1302–1309.
195. Perez-Hernandez, D., Gutierrez-Vazquez, J., Yanez-Mo, M., The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes. J. Biol. Chem. 288 (2013), 11649–11661, 10.1074/jbc.M112.445304.
196. Strauss, K., Goebel, C., Runz, H., Mobius, W., Weiss, S., Feussner, I., Simons, M., Schneider, A., Exosome secretion ameliorates lysosomal storage of cholesterol in Niemann-Pick type C disease. J. Biol. Chem. 285 (2010), 26279–26288, 10.1074/jbc.M110.134775.
197. Deng, Z.B., Zhuang, X., Ju, S., Jiang, X., Mu, J., Liu, Y., Jiang, H., Zhang, L., Mobley, J., McClain, C., Feng, W., Grizzle, W., Yan, J., Miller, D., Kronenberg, M., Zhang, H.G., Exosome-like nanoparticles from intestinal mucosal cells carry prostaglandin E2 and suppress activation of liver NKT cells. J. Immunol. 190 (2013), 3579–3589.
198. Roberg-Larsen, H., Lund, K., Seterdal, K.E., Solheim, S., Vehus, T., Solberg, N., Krauss, S., Lundanes, E., Wilson, S.R., Mass spectrometric detection of 27-hydroxycholesterol in breast cancer exosomes. J. Steroid Biochem. Mol. Biol. 169 (2016), 22–28, 10.1016/j.jsbmb.2016.02.006 (pii: S0960-0760(16)30020-6).
199. Beloribi-Djefaflia, S., Vasseur, S., Guillaumond, F., Lipid metabolic reprogramming in cancer cells. Oncogene, 5, 2016, e189, 10.1038/oncsis.2015.49.
200. Deutschmann, A., Schlagenhauf, A., Leschnik, B., Hoffmann, K.M., Hauer, A., Muntean, W., Increased procoagulant function of microparticles in pediatric inflammatory bowel disease: role in increased thrombin generation. J. Pediatr. Gastroenterol. Nutr. 56 (2013), 401–407.
201. Leonetti, D., Reimund, J.M., Tesse, A., Viennot, S., Martinez, M.C., Bretagne, A.L., Andriantsitohaina, R., Circulating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions. PLoS One, 8, 2013, e73088, 10.1371/journal.pone.0073088.
202. Palkovits, J., Novacek, G., Kollars, M., Hron, G., Osterode, W., Quehenberger, P., Kyrle, P.A., Vogelsang, H., Reinisch, W., Papay, P., Weltermann, A., Tissue factor exposing microparticles in inflammatory bowel disease. J. Crohns Colitis 7 (2013), 222–229, 10.1016/j.crohns.2012.05.016.
203. Mitsuhashi, S., Feldbruegge, L., Csizmadia, E., Mitsuhashi, M., Robson, S.C., Moss, A.C., Luminal extracellular vesicles in inflammatory bowel disease exhibit proinflammatory effects on epithelial cells and macrophages. Inflamm. Bowel Dis. 22 (2016), 1587–1595, 10.1097/MIB.0000000000000840.
204. Voudoukis, E., Vetsika, E.K., Giannakopoulou, K., Theodoropoulou, A., Sfiridaki, A., Georgouilas, V., Paspatis, G.A., Koutroubakis, I.E., Distinct features of circulating microparticles and their relationship with disease activity in inflammatory bowel disease. Ann. Gastroenterol. 29 (2016), 180–187, 10.20524/aog.2016.0010.
205. Gaetani, E., Marcantoni, M., Glaretta, I., Gatto, I., Scaldaferri, F., Del Zompo, F., Laterza, L., Tortora, A., Landi, R., Gassbarini, A., Pola, R., Circulating microvesicles in Crohn's disease. Abstract ECCO (European Crohn's and Colitis Organization) P093, 2014, Basic Sicence.
206. Mause, S.F., Weber, C., Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ. Res. 107 (2010), 1047–1057, 10.1161/CIRCRESAHA.110.226456.
207. Tual-Chalot, S., Leonetti, D., Andriantsitohaina, R., Martinez, M.C., Microvesicles: intercellular vectors of biological messages. Mol. Interv. 11 (2011), 88–94, 10.1124/mi.11.2.5.
208. Andoh, A., Tsujikawa, T., Hata, K., Araki, Y., Kitoh, K., Sasaki, M., Yoshida, T., Fujiyama, Y., Elevated circulating platelet-derived microparticles in patients with active inflammatory bowel disease. Am. J. Gastroenterol. 100 (2005), 2042–2048.
209. Chamouard, P., Desprez, D., Hugel, B., Kunzelmann, C., Gidon-Jeangirard, C., Lessard, M., Baumann, R., Freyssinet, J.M., Grunebaum, L., Circulating cell-derived microparticles in Crohn's disease. Dig. Dis. Sci. 50 (2005), 574–580.
210. Pamuk, G.E., Vural, O., Turgut, B., Demir, M., Umit, H., Tezel, A., Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study. Am. J. Hematol. 81 (2006), 753–759.
211. Tziatzios, G., Polymeros, D., Spathis, A., Triantafyllou, M., Gkolfakis, P., Karakitsos, P., Dimitriadis, G., Triantafyllou, K., Increased levels of circulating platelet derived microparticles in Crohn's disease patients. Scand. J. Gastroenterol. 51 (2016), 1184–1192, 10.1080/00365521.2016.1182582.
212. Li, Y., An, J., Huang, S., He, J., Zhang, J., Esophageal cancer-derived microvesicles induce regulatory B-cells. Cell Biochem. Funct. 33 (2015), 308–313, 10.1002/cbf.3115.
213. Weber, J.A., Baxter, D.H., Zhang, S., Huang, D.Y., Lee, M.J., Galas, D.J., Wang, K., The microRNA spectrum in 12 body fluids. Clin. Chem. 56 (2010), 1733–1741, 10.1373/clinchem.2010.147405.
214. Xi, Y., Nakajima, G., Gavin, E., Morris, C.G., Kudo, K., Hayashi, K., Ju, J., Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 13 (2007), 1668–1674.
215. Meng, W., McElroy, J.P., Volinia, S., Palatini, J., Warner, S., Ayers, L.W., Palanichamy, K., Chakravarti, A., Lautenschlaeger, T., Comparison of microRNA deep sequencing of matched formalin-fixed parafin-embedded and fresh frozen cancer tissues. PLoS One, 8, 2013, e64393, 10.1371/journal.pone.0064393.
216. Pescoe, S.B., Barber, J.R., Zheng, Q., Meeker, A.K., De Marzo, A.M., Platz, E.A., Lupold, S.E., Differential long-term stability of microRNAs and RNU6B snRNA in 12-20 year old formalin-fixed paraffin-embedded specimens. BMC Cancer, 17, 2017, 32, 10.1186/s12885-016-3008-4.
217. Arroyo, J.D., Chevillet, J.R., Kroh, E.M., Ruf, I.K., Pritchard, C.C., Gibson, D.F., Mitchell, P.S., Bennett, C.F., Pogosova-Agadjanyan, E.L., Stirewalt, D.L., Tait, J.F., Tewari, M., Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in the human plasma. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 5003–5008, 10.1073/pnas.1019055108.
218. Vickers, K.C., Palmisano, B.T., Shoucri, B.M., Shamburek, R.D., Remaley, A.T., MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13 (2011), 423–433, 10.1038/ncb2210.
219. Li, L., Zhu, D., Huang, L., Zhang, J., Bian, Z., Chen, X., Liu, Y., Zhang, C.Y., Zen, K., Argonaute2 complexes selectively protect the circulating microRNAs in cell-secreted microvesicles. PLoS One, 7, 2012, e4, 10.1371/journal.pone.0046957.
220. Ostenfeld, M.S., Jensen, S.G., Jeppesen, D.K., Christensen, L.L., Thorsen, S.B., Stenvang, J., Hvam, M.L., Thomsen, A., Mouritzen, P., Rasmussen, M.H., Nielsen, H.J., Ørntoft, T.F., Andersen, C.L., miRNA profiling of circulating EpCAM(+) extracellular vesicles: promising biomarkers of colorectal cancer. J. Extracell. Vesicles, 5, 2016, 31488, 10.3402/jev.v5.31488.
221. Yang, X., Zeng, Z., Hou, Y., Yuan, T., Gao, C., Jia, W., Yi, X., Liu, M., MicroRNA-92a as a potential biomarker in diagnosis of colorectal cancer: a systematic review and meta-analysis. PLoS One, 9, 2014, e88745, 10.1371/journal.pone.0088745.
222. Zeng, W., Tu, Y., Zhu, Y., Wang, Z., Li, C., Lao, L., Wu, G., Predictive power of circulating miRNAs in detecting colorectal cancer. Tumour Biol. 36 (2015), 2559–2567, 10.1007/s13277-014-2872-2.
223. Fang, Z., Tang, J., Bai, Y., Lin, H., You, H., Jin, H., Lin, L., You, P., Li, J., Dai, Z., Liang, X., Su, Y., Hu, Q., Wang, F., Zhang, Z.Y., Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma. J. Exp. Clin. Cancer Res., 34, 2015, 86, 10.1186/s13046-015-0198-6.
224. Chen, W.Y., Zhao, X.J., Yu, Z.F., Hu, F.L., Liu, Y.P., Cu, B.B., Dong, X.S., Zhao, Y.S., The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer. Int. J. Clin. Exp. Pathol. 8 (2015), 7092–7101.
225. Oikonomopoulos, A., Polytarchou, C., Joshi, S., Hommes, D.W., Iliopoulos, D., Identification of circulating microRNA signatures and Crohn's disease using the nanostring nCounter technology. Inflamm. Bowel Dis. 22 (2016), 2063–2069, 10.1097/MIB.0000000000000883.
226. Wang, H., Zhang, S., Yu, Q., Yang, G., Guo, J., Li, M., Zeng, Z., He, Y., Chen, B., Chen, M., Circulating microRNA223 is a new biomarker for inflammatory bowel disease. Medicine (Baltimore), 95, 2016, e2703, 10.1097/MD.0000000000002703.
227. Pritchard, C.C., Kroh, E., Wood, B., Arroyo, J.D., Dougherty, K.J., Miyaji, M.M., Tait, J.F., Tewari, M., Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev. Res. (Phila.) 5 (2012), 492–497, 10.1158/1940-6207.CAPR-11-0370.
228. Haider, B.A., Baras, A.S., McCall, M.N., Hertel, J.A., Cornish, T.C., Halushka, M.K., A critical evaluation of microRNA biomarkers in non-neoplastic disease. PLoS One, 9, 2014, e89565, 10.1371/journal.pone.0089565.
229. Junttila, M.R., de Sauvage, F.J., Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501 (2013), 346–354, 10.1038/nature12626.
230. Hölzel, M., Bovier, A., Tṻting, T., Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?. Nat. Rev. Cancer 13 (2013), 365–376, 10.1038/nrc3498.
231. Caronni, N., Savino, B., Bonecchi, R., Myeloid cells in cancer-related inflammation. Immunobiology 220 (2015), 249–253.
232. Azmi, A.S., Bao, B., Sarkar, F.H., Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev. 32 (2013), 623–642.
233. Zhang, L., Zhang, S., Yao, J., Lowery, F.J., Zhang, Q., Huang, W.C., Li, P., Li, M., Wang, X., Zhang, C., Wang, H., Ellis, K., Cheerathodi, M., McCarty, J.H., Palmieri, D., Saunus, J., Lakhani, S., Huang, S., Sahin, A.A., Aldape, K.D., Steeg, P.S., Yu, D., Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature 527 (2015), 100–104, 10.1038/nature15376.
234. Becker, A., Thakur, B.K., Weiss, J.M., Kim, H.S., Peinado, H., Lyden, D., Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell 30 (2016), 836–848, 10.1016/j.ccell.2016.10.009.
235. Yoon, Y.J., Kim, D.K., Yoon, C.M., Park, J., Kim, Y.K., Roh, T.Y., Gho, Y.S., Egr-1 activation by cancer-derived extracellular vesicles promotes endothelial cell migration via ERK1/2 and JNK signaling pathways. PLoS One, 9, 2014, e115170, 10.1371/journal.pone.0115170.
236. Bhome, R., Goh, R., Pickard, K., Mellone, M., Sayan, A.E., Mirnezami, A., Profiling the microRNA payload of exosomes derived from ex vivo primary colorectal fibroblasts. Methods Mol. Biol. 1509 (2017), 115–122.
237. Nowell, P.C., The clonal evolution of tumor cell populations. Science 194 (1976), 23–28.
238. Maekita, T., Nakazawa, K., Mihara, M., Nakajima, T., Yanaoka, K., Iguchi, M., Arii, K., Kaneda, A., Tsukamoto, T., Tatematsu, M., Tamura, G., Saito, D., Sugimura, T., Ichinose, M., Ushijima, T., High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin. Cancer Res. 12 (2006), 989–995.
239. Nakajima, T., Enomoto, S., Yamashita, S., Ando, T., Nakanishi, Y., Nakazawa, K., Oda, I., Gotoda, T., Ushijima, T., Persistence of a component of DNA methylation in gastric mucosae after Helicobacter pylori eradication. J. Gastroenterol. 45 (2010), 37–44, 10.1007/s00535-009-0142-7.
240. Fukushige, S., Horii, A., Road to early detection of pancreatic cancer. Attempts to utilize epigenetic biomarkers. Cancer Lett. 342 (2014), 231–237, 10.1016/j.canlet.2012.03.022.
241. Yi, J.M., Guzzetta, A.A., Bailey, V.J., Downing, S.R., Van Neste, L., Chiapinelli, K.B., Keeley, B.P., Stark, A., Herrera, A., Wolfgang, C., Pappou, E.P., Iacobuzio-Donahue, C.A., Goggins, M.G., Herman, J.G., Wang, T.H., Baylin, S.B., Ahuja, N., Novel methylation biomarker panel for the early detection of pancreatic cancer. Clin. Cancer Res. 19 (2013), 6544–6555, 10.1158/1078-0432.CCR-12-3224.
242. Lidar, M., Langewitz, P., Shoenfeld, Y., The role of infection in inflammatory bowel disease: initiation, excerebration and protection. Isr. Med. Assoc. J. 11 (2009), 558–563.
243. Taurog, J.D., Richardon, J.A., Croft, J.T., Simmons, W.A., Zhou, M., Fernández-Sueiro, J.L., Balish, E., Hammer, R.E., The germ-free state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180 (1994), 2359–2364.
244. Strober, W., Fuss, I.J., Blumberg, R.S., The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20 (2002), 495–549.
245. Castellarin, M., Warren, R.L., Freeman, J.D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R.A., Holt, R.A., Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22 (2012), 299–306, 10.1101/gr.126516.111.
246. Irrazabal, T., Belcheva, A., Girardin, S.E., Martin, A., Philpott, D.J., The multifaceted role of the intestinal microbiota in colon cancer. Mol. Cell 54 (2014), 309–320, 10.1016/j.molcel.2014.03.039.
247. Rubin, D.C., Shaker, A., Levin, M.S., Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front. Immunol., 3, 2012, 107, 10.3389/fimmu.2012.00107.
248. Gill, S.R., Pop, M., Deboy, R.T., Eckburg, P.B., Turnbaugh, P.J., Samuel, B.S., Gordon, J.I., Relman, D.A., Fraser-Liggett, C.M., Nelson, K.E., Metagenomic analysis of the human distal gut microbiome. Science 312 (2005), 1355–1359.
249. Backhed, F., Ley, R.E., Sonnenburg, J.L., Peterson, D.A., Gordon, J.L., Host-bacterial mutualism in the human intestine. Science, 307(2005), 1915-1920.
250. Turnbaugh, P.J., Ley, R.E., Hamady, M., Fraser-Ligett, C.M., Knight, R., Gordon, J.I., The human microbiome project. Nature 449 (2007), 804–810.
251. Wexler, H.M., Finegold, S.M., Current susceptability patterns of anaerobic bacteria. Yonsei Med. J. 39 (1998), 495–501.
252. Wang, T., Cai, G., Qiu, Y., Fei, N., Zhang, M., Pang, X., Jia, W., Cai, S., Zhao, L., Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 6 (2012), 320–329, 10.1038/ismej.2011.109.
253. Viljoen, K.S., Dakshinamurthy, A., Goldberg, P., Blackburn, J.M., Quantitative profiling of colorectal-associated bacteria reveals associations between Fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer. PLoS One, 10, 2015, e0119462, 10.1371/journal.pone.0119462.
254. Rubinstein, M.R., Wang, X., Liu, W., Hao, Y., Cai, G., Han, Y.W., Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14 (2013), 195–206, 10.1016/j.chom.2013.07.012.
255. Boleij, A., Hechenbleikner, E.M., Goodwin, A.C., Badani, R., Stein, E.M., Lazarev, M.G., Ellis, B., Carroll, K.C., Albesiano, E., Wick, E.C., Platz, E.A., Pardoll, D.M., Sears, C.L., The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin. Infect. Dis. 60 (2015), 208–215, 10.1093/cid/ciu787.
256. Andersen-Nissen, E., Smith, K.D., Strobe, K.L., Rassoulian Barrett, S.L., Cookson, B.T., Logan, S.M., Aderem, A., Evasion of Toll-like receptor 5 by flagellated bacteria. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 9247–9252, 10.1073/pnas.0502040102.[SPACE].
257. Kim, J.H., Lee, J., Park, J., Gho, Y.S., Gram-negative and gram-positive bacterial extracellular vesicles. Semin. Cell Dev. Biol. 40 (2015), 97–104, 10.1016/j.semcdb.
258. Celluzzi, A., Masotti, A., How our other genome controls our epi-genome. Trends Microbiol. 24 (2016), 777–787, 10.1016/j.tim.2016.05.005.
259. Kinder, S.A., Holt, S.C., Localization of the Fusobacterium nucleatum T18 adhesin activity mediating coaggreagation with Porphyromonas gingivalis T22. J. Bacteriol. 175 (1993), 840–850.
260. Patrick, S., McKenna, J.P., Hagan, S.O., Dermott, E., A comparison of the hemagglutinating and enzymatic activities of Bacteroides fragilis whole cells and outer membrane vesicles. Microb. Pathog. 20 (1996), 191–202.
261. Keenan, J., Day, T., Neal, S., Cook, B., Perez-Perez, G., Allardyce, R., Bagshaw, P., A role for the bacterial outer membrane in the pathogenesis of Helicobacter pylori infection. FEMS Microbiol. Lett. 182:260 (2000), 259–264.
262. Ismail, S., Hampton, M.B., Keenan, J.I., Helicobacter pylori outer membrane vesicles modulate proliferation and interleukin-8 production by gastric epithelial cells. Infect. Immun. 71 (2010), 5670–5675.
263. Rolhion, N., Barnich, N., Claret, L., Darfeuille-Michaud, A., Strong decrease in invasive ability and outer membrane vesicles release in Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 with the yfgL gene deleted. J. Bacteriol. 187 (2005), 2286–2296.
264. Chu, H., Khosravi, A., Kusumwardhani, I.P., Kwon, A.H.K., Vasconcelos, A.C., Cunha, L.D., Mayer, A.E., Shen, Y., Wu, W.L., Kambal, A., Targan, S.R., Xavier, R.J., Ernst, P.B, Green, D.R., McGovern, D.P., Virgin, H.W., Mazmanian, S.K., Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science 352:6289 (2016), 1116–1120, 10.1126/science.aad9948.
265. Shen, Y., Giardino Torchia, M.L., Lawson, G.W., Karp, C.L., Ashwell, J.D., Mazmanian, S.K., Outer membrane vesicles of a human commensal mediate regulation and disease protection. Cell Host Microbe 12 (2012), 509–520, 10.1016/j.chom.2012.08.004.
266. Stentz, R., Horn, N., Cross, K., Salt, L., Brearley, C., Livermore, D.M., Carding, S.R., Cephalosporinases associated with outer membrane vesicles released by Bacteroides sp. protect gut pathogens and commensals against β-lactam antibiotics. J. Antimicrob. Chemother. 70 (2015), 701–709, 10.1093/jac/dku466.
267. Mu, J., Zhuang, X., Wang, Q., Jiang, H., Deng, Z.B., Wang, B., Zhang, L., Kakar, S., Jun, Y., Miller, D., Zhang, H.G., Interspecies communication between plant and mouse gut host cells through edible plant derived exosome-like nanoparticles. Mol. Nutr. Food Res. 58 (2014), 1561–1573, 10.1002/mnfr.201300729.
268. Simbari, F., McCaskill, J., Coakley, G., Millar, M., Maizels, R.M., Fabrias, G., Casas, J., Buck, A.H., Plasmalogen enrichment in exosomes secreted by a nematode parasite versus those derived from its mouse host: implications for exosome stability and biology. J. Extracel. Vesicles, 5, 2016, 30741, 10.3402/jev.v5.30741.
269. Buck, A.H., Coakley, G., Simbary, F., McSorley, H.J., Quintana, J.F., Le Bihan, T., Kumar, S., Abreu-Goodger, C., Lear, M., Harcus, Y., Ceroni, Y., Babayan, S.A., Blaxter, M., Ivens, A., Maizels, R.M., Exosomes secreted by nematode parasites transfer small RNAs to mammalian cells and modulate innate immunity. Nat. Commun., 5, 2014, 5488, 10.1038/ncomms6488.
270. Nowacki, F.C., Swain, M.T., Klychnikov, O.I., Niazi, U., Ivens, A., Quintana, J.F., Hensbergen, P.J., Hokke, C.H., Buck, A.H., Hoffmann, K.F., Protein and small non-coding RNA-enriched extracellular vesicles are released by the pathogenic blood fluke Schistosoma mansoni. J. Extracel. Vesicles, 4, 2015, 28665, 10.3402/jev.v4.28665.
271. Wang, L., Li, Z., Shen, J., Liu, Z., Liang, J., Wu, X., Sun, X., Wu, Z., Exosome-like vesicles derived by Schistosoma japonicum adult worms mediates M1 type immune activity of macrophage. Parasitol. Res. 114 (2015), 1865–1873, 10.1007/s00436-015-4373-7.
272. Barteneva, N.S., Maltsev, N., Vorobjev, I.A., Microvesicles and intercellular communication in the context of parasitism. Front. Cell. Infect. Microbiol., 3, 2013, 49, 10.3389/fcimb.2013.00049.
273. Fabbri, M., Paone, A., Calore, F., Galli, R., Gaudio, E., Santhanam, R., Lovat, F., Fadda, P., Mao, C., Nuovo, G.J., Zanesi, N., Crawford, M., Ozer, G.H., Wernicke, D., Alder, H., Caligiuri, M.A., Nana-Sinkam, P., Perrotti, D., Croce, C.M., MicroRNAs bind to Toll-like receptors to induce prometastatic inflammtory response. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), E2110–E2116, 10.1073/pnas.1209414109.
274. Oldenburg, M., Kruger, A., Ferstl, R., Kaufmann, A., Nees, G., Sigmund, A., Bathke, B., Lauterbach, H., Suter, M., Dreher, S., Koedel, U., Akira, S., Kawai, T., Buer, J., Wagner, H., Bauer, S., Hochrein, H., Kirschning, C.J., TLR13 recognizes bacterial 23S rRNA devoid of erythromycin-resistance forming modification. Science 337 (2012), 1111–1115, 10.1126/science.1220363.
275. Broz, P., Monack, D.M., Newly described pattern recognition receptors team up against intracellular pathogens. Nat. Rev. Immunol. 13 (2013), 551–565.
276. Robinson, K.M., Dunning Hotopp, J.C., Mobile elements and viral integrations prompt considerations for bacterial DNA integration as a novel carcinogen. Cancer Lett. 352 (2014), 137–144, 10.1016/j.canlet.2014.05.021.
277. Sieber, K.B., Bromley, R.E., Dunning Hotopp, J.C., Lateral gene transfer between procaryotes and eukaryotes. Exp. Cell Res., 2017, 10.1016/j.yexcr.2017.02.009 (EPub Feb 9. pii: S0014-4827(17)30054-X).
278. Hintermann, E., Holdener, M., Bayer, M., Loges, S., Pfeilschifter, J.M., Granier, C., Manns, M.P., Christen, U., Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model. J. Autoimmun. 37 (2011), 242–253, 10.1016/j.jaut.2011.06.005.
279. Ruff, W.E., Kriegel, M.A., Autoimmune host-microbiota interactions at barrier sites and beyond. Trends Mol. Med. 21 (2015), 233–244, 10.1016/j.molmed.2015.02.006.
280. + plasmablasts in the human gut are antigen-specific. J. Clin. Invest. 121 (2011), 1946–1955, 10.1172/JCI44447.
281. Choi, D.-S., Park, J.O., Jang, S.C., Yoon, Y.J., Jung, J.W., Choi, D.-Y., Kim, J.-W., Kang, J.S., Park, J., Hwang, D., Lee, K.-H., Park, S.H., Kim, Y.-K., Desiderio, D.M., Kim, K.P., Gho, Y.S., Proteomic analysis of microvesicles from human colorectal cancer ascites. Proteomics 11 (2011), 2745–2751, 10.1002/pmic.201100022.
282. Choi, D.-S., Yang, J.-S., Choi, E.-J., Jang, S.C., Park, S., Kim, O.Y., Hwang, D., Kim, K.P., Kim, Y.-K., Kim, S., Gho, Y.S., The protein interaction network of extracellular vesicles derived from human colorectal cancer cells. J. Proteome Res. 11 (2012), 1144–1151, 10.1021/pr200842h.
283. Conradi, J., Huber, S., Gaus, K., Mertink, F., Royo Gracia, S., Strijowski, U., Backert, S., Sewald, N., Cyclic RGD peptides interfere with binding of the Helicobacter pylori protein CagL to integrins aVß3 and a5ß1. Amino Acids 43 (2012), 219–232, 10.1007/s00726-011-1066-0.
284. Barden, S., Lange, S., Tegtmeyer, N., Conradi, J., Sewald, N., Backert, S., Niemann, H.H., A helicalRGD motif promoting cell adhesion: crystal structures of the Helicobacter pylori type IV secretion system pilus protein CagL. Structure 21 (2013), 1931–1941, 10.1016/j.str.2013.08.018.
285. Wu, H., Downs, D., Ghosh, K., Ghosh, A.K., Staib, P., Monod, M., Tang, J., Candida albicanssecreted aspartic proteases induce apoptosis of epithelial cells by a novel Trojan horse mechanism. FASEB J. 27 (2013), 2132–2144, 10.1096/fj.12-214353.
286. Polle, L., Rigano, L.A., Julian, R., Ireton, K., Schubert, W.D., Structural details of human tubarecruitment by InIC of Listeria monocytogenes elucidate bacterial cell-cell spreading. Structure 22 (2014), 304–314, 10.1016/j.str.2013.10.017.
287. Nava-Acosta, R., Navarro-Garcia, F., Cytokeratin 8 is an epithelial cell receptor for pet, acytotoxic serine protease autotransporter of Enterobacteriaceae. MBio, 4, 2013, e00838-13, 10.1128/mBio.00838-13.
288. Batchelor, M., Guignot, J., Patel, A., Cummings, N., Cleary, J., Knutton, S., Holden, D.W., Connerton, I., Frankel, G., Involvement of the intermediate filament protein cytokeratin-18 in actinpedestal formation during EPEC infection. EMBO Rep. 5 (2004), 104–110.
289. Scherer, C.A., Cooper, E., Miller, S.I., The Salmonella type III secretion translocon protein SspC isinserted into the epithelial cell plasma membrane upon infection. Mol. Microbiol. 37 (2000), 1133–1145.
290. Carlson, S.A., Omary, M.B., Jones, B.D., Identification of cytokeratins as accessory mediators ofSalmonella entry into eukaryotic cells. Life Sci. 70 (2002), 1415–1426.
291. Russo, B.C., Stamm, L.M., Raaben, M., Kim, C.M., Kahoud, E., Robinson, L.R., Bose, S., Queiroz, A.L., Herrera, B.B., Baxt, L.A., Mor-Vaknin, N., Fu, Y., Molina, G., Markowitz, D.M., Whelan, S.P., Goldberg, M.B., Intermediate filaments enable pathogen docking to trigger type 3 effector translocation. Nat. Microbiol., 1, 2016, 16025, 10.1038/nmicrobiol.2016.25.
292. Samen, U., Eikmanns, B.J., Reinscheid, D.J., Borges, F., The surface protein Srr-1 of Streptococcus agalactiae binds human keratin 4 and promotes adherence to epithelial HEp-2 cells. Infect. Immun. 75 (2007), 5405–5414.
293. Schulte, T., Loefling, J., Mikaelsson, C., Kikhney, A., Hentrich, K., Diamante, A., Ebel, C., Normark, S., Svergun, D., Henriques-Normark, B., Achour, A., The basic keratin 10-binding domain of the virulence-associated pneumococcal serine-rich PsrP adopts a novel MSCRAMM fold. Open Biol., 4, 2014, 130090, 10.1098/rsob.130090.
294. Ramboarina, S., Garnett, J.A., Zhou, M., Li, Y., Peng, Z., Taylor, J.D., Lee, W.C., Bodey, A., Murray, J.W., Alguel, Y., Bergeron, J., Bardiaux, B., Sawyer, E., Isaacson, R., Tagliaferi, C., Cota, E., Nilges, M., Simpson, P., Ruiz, T., Wu, H., Matthews, S., Structural insights into serine-rich fimbriae from gram-positive bacteria. J. Biol. Chem. 285 (2010), 32446–32457, 10.1074/jbc.M110.128165.
295. Cao, Y., Multifarious functions of PDGFs and PDGFRs in tumour grouth and metastasis. Trends Mol. Med. 19 (2013), 460–473, 10.1016/j.molmed.2013.05.002.
296. Demoulin, J.-B., Essaghir, A., PDGF receptor signaling networks in normal and cancer cells. Cytokine Growth Factor Rev. 25 (2014), 273–283, 10.1016/j.cytogfr.2014.03.003.
297. Manzat Saplacan, R.M., Balacescu, L., Gherman, C., Chira, R.I., Craiu, A., Mircea, P.A., Lisencu, S., Balacescu, O., The role of PDGFs and PDGFRs in colorectal cancer. Mediat. Inflamm., 2017, 2017, 4708076, 10.1155/2017/4708076.
298. Mantur, M., Koper, O., Snarska, J., Sidorska, A., Kruszewska-Wnorowska, K., Evaluation of PDGF-AB and sP-selectin concentrations in relation to platelet count in patients with colorectal cancer before and after surgical treatment. Pol. Arch. Med. Wewn. 118 (2008), 234–250.
299. Yu, J., Ustach, C., Kim, H.-R.C., Platelet-derived growth factor signaling and human cancer. J. Biochem. Mol. Biol. 36 (2003), 49–59.
300. Boudeau, J., Miranda-Saavedra, D., Barton, G.J., Alessi, D.R., Emerging roles of pseudokinases. Trends Cell Biol. 16 (2006), 443–452, 10.1016/j.tcb.2006.07.003.
301. Heiler, S., Wang, Z., Zoeller, M., Pancreatic cancer stem cells and exosomes-the incentive push. World J. Gastroenterol. 22 (2016), 5971–6007, 10.3748/wjg.v22.i26.5971.
302. Jimenez, C.R., Knol, J.C., Meijer, G.A., Fijneman, R.J., Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers. J. Proteome 73 (2010), 1873–1895, 10.1016/j.jprot.2010.06.004.
303. Alvarez-Chaver, P., Otero-Estevez, O., Paez de la Cadena, M., Rodriguez-Berrocal, F.J., Martinez-Zorzano, V.S., Proteomics for discovery of candidate colorectal cancer biomarkers. World J. Gastroenterol. 20 (2014), 3804–3824, 10.3748/wjg.v20.i14.3804.